SCIEX’s Jose Castro-Perez Reveals How Theyre Setting New Standards in Mass Spectrometry
Summary
In this interview, we sit down with Jose Castro-Perez, Vice President of Product Management at SCIEX, to discuss his journey in the life sciences sector and the innovative Echo® MS+ system launched at SLAS 2024. Further post-graduate study concluded in obtaining a Ph.D. (Dynamic System-Wide Mass Spectrometry based Metabolomics Approach for a New Era in Drug Research) at the University of Leiden (The Netherlands). Following my tenure at Huntingdon Life Sciences, I held various bioanalytical leadership positions at Merck, Waters Corporation and Agios Pharmaceuticals supporting Target ID/Validation, DMPK, Biomarker Discovery/Development, and Translational Clinical Research. We highly value our customer interactions as not only do we learn from their challenges, but we work hard to innovate to answer critical needs where it matters the most and that is to try to help to bring new therapies to the market. We collaborated with customers before the launch of the product to help them to address their needs and as a result we also learned more about best analytical conditions which will fit a high variety of workflows.